Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Apr 18;15(2):83-93.
doi: 10.1016/j.aju.2017.03.005. eCollection 2017 Jun.

Medical expulsive therapy for ureteric stones: Analysing the evidence from systematic reviews and meta-analysis of powered double-blinded randomised controlled trials

Affiliations
Review

Medical expulsive therapy for ureteric stones: Analysing the evidence from systematic reviews and meta-analysis of powered double-blinded randomised controlled trials

Tarik Amer et al. Arab J Urol. .

Abstract

Objective: To conduct a systematic review and meta-analysis investigating the efficacy and safety of medical expulsive therapy (MET) in low risk of bias (RoB) randomised controlled trials (RCTs).

Methods: A Cochrane style systematic review was conducted on published literature from 1990 to 2016, to include low RoB and a power calculation. A pooled meta-analysis was conducted.

Results: The MET group included 1387 vs 1381 patients in the control group. The analysis reveals α-blockers increased stone expulsion rates (78% vs 74%) (P < 0.001), whilst calcium channel blockers (CCBs) had no effect compared to controls (79% vs 75%) (P = 0.38). In the subgroup analysis, α-blockers had a shorter time to stone expulsion vs the control group (P < 0.001). There were no significant differences in expulsion rates between the treatment groups and control group for stones <5 mm in size (P = 0.48), proximal or mid-ureteric stones (P = 0.63 and P = 0.22, respectively). However, α-blockers increased stone expulsion in stones >5 mm (P = 0.02), as well as distal ureteric stones (P < 0.001). The α-blocker group developed more side-effects (6.6% of patients; P < 0.001). The numbers needed to treat for α-blockers was one in 14, for stones >5 mm one in eight, and for distal stones one in 10.

Conclusion: The primary findings show a small overall benefit for α-blockers as MET for ureteric stones but no benefit with CCBs. α-blockers show a greater benefit for large (>5 mm) ureteric stones and those located in the distal ureter, but no benefit for smaller or more proximal stones. α-blockers are associated with a greater risk of side-effects compared to placebo or CCBs.

Keywords: ARR, absolute risk reduction; CCB, calcium channel blocker; Calcium channel blockers; MD, mean difference; MET, medical expulsive therapy; MeSH, medical subject headings; Medical expulsive therapy (MET); NNT, numbers needed to treat; RCT, randomised controlled trial; RR, risk ratio; RoB, risk of bias; Ureteric stones; Urinary stones; α-Blockers.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flowchart for article selection process of the review.
Fig. 2
Fig. 2
MET overall expulsion rates.
Fig. 3
Fig. 3
MET secondary outcomes.
Fig. 3
Fig. 3
MET secondary outcomes.
Fig. 4
Fig. 4
RoB table.

References

    1. Pak C.Y. Kidney stones. Lancet. 1998;351:1797–1801. - PubMed
    1. Ramello A., Vitale C., Marangella M. Epidemiology of nephrolithiasis. J Nephrol. 2000;13(Suppl. 3):S45–S50. - PubMed
    1. Ahmad H., Azim W., Akmal M., Murtaza B., Mahmood A., Nadim A. Medical expulsive treatment of distal ureteral stone using tamsulosin. J Ayub Med Coll Abbottabad. 2015;27:48–50. - PubMed
    1. Hollingsworth J.M., Rogers M.A., Kaufman S.R., Bradford T.J., Saint S., Wei J.T. Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet. 2006;368:1171–1179. - PubMed
    1. Miller O.F., Kane C.J. Time to stone passage for observed ureteral calculi: a guide for patient education. J Urol. 1999;162:688–691. - PubMed

LinkOut - more resources